Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]

Total article views   HTML views PDF downloads Totals
6,986 Dovepress* 6,884+ 1,425 8,309
PubMed Central* 102 48 150
Totals 6,986 1,473 8,459
*Since 19 April 2017

View citations on PubMed Central and Google Scholar